Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men

Endocrine

Volumn 50, Issue 3, 2015, Pages 650-658

  Ryoo, Jae Hong ^a   Park, Sung Keun ^a,b   Ye, Sungmin ^c   Choi, Joong Myung ^a   Oh, Chang Mo ^d   Kim, Sun Yong ^b   Shin, Ju Young ^e   Park, Jai Hyung ^b   Hong, Hyun Pyo ^b   Ko, Taeg Su ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

^e Korea Institute of Drug Safety and Risk Management   (South Korea)

Author keywords

Diabetes; Metabolic health; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE PREDISPOSITION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH STATUS; HUMAN; INCIDENCE; KOREAN (PEOPLE); MALE; METABOLIC PARAMETERS; METABOLICALLY HEALTHY NORMAL WEIGHT; METABOLICALLY HEALTHY OBESE; METABOLICALLY HEALTHY OVERWEIGHT; METABOLICALLY UNHEALTHY NORMAL WEIGHT; METABOLICALLY UNHEALTHY OBESE; METABOLICALLY UNHEALTHY OVERWEIGHT; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; COMPLICATION; METABOLISM; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; SOUTH KOREA;

ADULT; DIABETES MELLITUS; HUMANS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK ASSESSMENT;

EID: 84949113989     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0635-5     Document Type: Article

References (38)

1. N. Stefan, H.U. Häring, F.B. Hu, M.B. Schulze, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1, 152–162 (2013)
2. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks, Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289, 76–79 (2003)
3. G.M. Hinnouho, S. Czernichow, A. Dugravot, G.D. Batty, M. Kivimaki, A. Singh-Manoux, Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36, 2294–2300 (2013)
4. Y. Chang, B.K. Kim, K.E. Yun, J. Cho, Y. Zhang, S. Rampal, D. Zhao, H.S. Jung, Y. Choi, J. Ahn, J.A. Lima, H. Shin, E. Guallar, S. Ryu, Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679–2686 (2014)
5. P.M. Janiszewski, R. Ross, Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 33, 1957–1959 (2010)
6. M. Hamer, G.D. Batty, M. Kivimaki, Risk of future depression in people who are obese but metabolically healthy: the english longitudinal study of ageing. Mol. Psychiatry 17, 940–945 (2012)
7. J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006)
8. S.L. Appleton, C.J. Seaborn, R. Visvanathan, C.L. Hill, T.K. Gill, A.W. Taylor, R.J. Adams, North West Adelaide Health Study Team, Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype a cohort study. Diabetes Care 36, 2388–2394 (2013)
9. F. Hadaegh, M. Bozorgmanesh, M. Safarkhani, D. Khalili, F. Azizi, Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome? BMC Public Health 11, 1–9 (2011)
10. F. Soriguer, C. Gutiérrez-Repiso, E. Rubio-Martín, E. García-Fuentes, M.C. Almaraz, N. Colomo, I. Esteva de Antonio, M.S. de Adana, F.J. Chaves, S. Morcillo, S. Valdés, G. Rojo-Martínez, Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 98, 2318–2325 (2013)
11. D. Luo, F. Liu, X. Li, D. Yin, Z. Lin, H. Liu, X. Hou, C. Wang, W. Jia, Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine 49, 130–138 (2015)
12. S.K. Park, M.H. Seo, H.C. Shin, J.H. Ryoo, Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 57, 1378–1383 (2013)
13. American Diabetes Association, Standards of medical care in diabetes—2010. Diabetes Care 33(Suppl 1), S11–S61 (2010)
14. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)
15. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, Lente F. Van, T. Greene, J. Coresh, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)
16. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, M. Hurley, K.D. Mullen, J.N. Cooper, M.J. Sheridan, The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002)
17. S.H. Saverymuttu, A.E. Joseph, J.D. Maxwell, Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. (Clin Res Ed) 292, 13–15 (1986)
18. R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F.L. Brancati, E. Guallar, J.M. Clark, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1982–1990 (2011)
19. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii:1–253 (2000)
20. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168, 1617–1624 (2008)
21. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on epidemiology and prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International atherosclerosis Society; and International association for the study of obesity. Circulation 120, 1640–1645 (2009)
22. J.L. Kuk, C.I. Ardern, Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32, 2297–2299 (2009)
23. L.C. Hwang, C.H. Bai, C.A. Sun, C.J. Chen, Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac. J. Clin. Nutr. 21, 227–233 (2012)
24. E.-J. Rhee, M.K. Lee, J.D. Kim, W.S. Jeon, J.C. Bae, S.E. Park, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 9, e98369 (2014)
25. A. Mor, E. Svensson, J. Rungby, S.P. Ulrichsen, K. Berencsi, J.S. Nielsen, J.V. Stidsen, S. Friborg, I. Brandslund, J.S. Christiansen, H. Beck-Nielsen, H.T. Sørensen, R.W. Thomsen, Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. Diabetes Metab. Res. Rev. 30, 707–715 (2014)
26. N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, H.U. Häring, Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609–1616 (2008)
27. Y. Chang, H.S. Jung, K.E. Yun, J. Cho, Y.K. Cho, S. Ryu, Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am. J. Gastroenterol. 108, 1861–1868 (2013)
28. K.C. Sung, S.H. Wild, C.D. Byrne, Resolution of fatty liver and risk of incident diabetes. J. Clin. Endocrinol. Metab. 98, 3637–3643 (2013)
29. M. Hamer, E. Stamatakis, Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97, 2482–2488 (2012)
30. C.M. Durward, T.J. Hartman, S.M. Nickols-Richardson, All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J. Obes. 2012, 460321 (2012)
31. K. Aung, C. Lorenzo, M.A. Hinojosa, S.M. Haffner, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J. Clin. Endocrinol. Metab. 99, 462–468 (2014)
32. C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013)
33. J.A. Bell, M. Kivimaki, M. Hamer, Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes. Rev. 15, 504–515 (2014)
34. B.J. Arsenault, M. Côté, A. Cartier, I. Lemieux, J.P. Després, R. Ross, C.P. Earnest, S.N. Blair, T.S. Church, Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 207, 530–533 (2009)
35. M.J. Shin, Y.J. Hyun, O.Y. Kim, J.Y. Kim, Y. Jang, J.H. Lee, Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes. (Lond) 30, 1529–1534 (2006)
36. K. Kantartzis, J. Machann, F. Schick, K. Rittig, F. Machicao, A. Fritsche, H.U. Häring, N. Stefan, Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54, 864–868 (2011)
37. A. Koster, S. Stenholm, D.E. Alley, L.J. Kim, E.M. Simonsick, A.M. Kanaya, M. Visser, D.K. Houston, B.J. Nicklas, F.A. Tylavsky, S. Satterfield, B.H. Goodpaster, L. Ferrucci, T.B. Harris, Health ABC Study: body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18, 2354–2361 (2010)
38. S.M. Camhi, P.T. Katzmarzyk, Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int. J. Obes. (Lond) 38, 42–1145 (2014)